Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1988 Sep;79(9):1048–1053. doi: 10.1111/j.1349-7006.1988.tb00073.x

Antitumor Activity and Neutrophil‐selective Hematopoietic Toxicity of Busulfan Analogs in Mice

Taketoshi Kato 1, Yuko Ohta 2, Yasuko Suzumura 1, Kohfuku Kohda 2, Hiroshi Kimoto 3, Yutaka Kawazoe 2,
PMCID: PMC5917621  PMID: 2848003

Abstract

The antitumor activity and hematopoietic toxicity of two busulfan analogs were evaluated in comparison with those of busulfan. Although a program of five daily ip treatments with busulfan was not effective in treating sarcoma 180‐bearing mice, a fluorine‐containing busulfan analog, 1,4‐butanediol di‐2,2,2‐trifluoroethanesulfonate (BFS), and a water‐soluble analog, 1,4‐butanediol diisethionate (BIT), were significantly effective when given on the same schedule. Busulfan did not appreciably prolong the life span of either P388‐ or Meth A‐bearing mice, whereas BFS and BIT produced significant increases in the life span. It is worth noting that both the analogs were definitely less toxic to the host mice than busulfan. All the drugs examined exhibited suppressive effects on the counts of total WBCs, neutrophils, and lymphocytes. Relative toxicity toward neutrophils versus lymphocytes was increased significantly in the BFS and BIT treatments compared with busulfan treatment. It seems that the toxicity of busulfan in host mice might be due to unidentified side effects other than bone marrow suppression. These results suggest that BFS and BIT could be improved substitutes for busulfan.

Keywords: Busulfan analog, Fluorinated busulfan, Isethionic acid ester, Neutrophil‐selective toxicity, Chronic myeloid leukemia

Full Text

The Full Text of this article is available as a PDF (272.2 KB).

References

  • 1).Bishop , J. B. and Wassom , J. S.Toxicological review of busulfan (Myleran) . Mutat. Res. , 168 , 15 – 45 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 2).Talpaz , M. , Kantarjian , H. M. , McCredie , K. B. , Keating , M. J. , Trujillo , J. and Gutterman , U. J.Clinical investigation of human alpha interferon in chronic myelogenous leukemia . Blood , 69 , 1280 – 1288 ( 1987. ). [PubMed] [Google Scholar]
  • 3).Ohta , Y. , Kohda , K. , Kimoto , H. , Okano , T. and Kawazoe , Y.Cytotoxicity of fluorine‐containing alkyl alkanesulfonates in cultured leukemia L1210 cells . Chem. Pharm. Bull. , 36 , 2410 – 2416 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 4).Kawazoe , Y. and Tamura , N.Synthesis and antitumor effect of new biological alkylating agents, isethionic acid esters . Gann , 72 , 862 – 867 ( 1981. ). [PubMed] [Google Scholar]
  • 5).Hoshi , A. , Kanzawa , F. and Kuretani , K.Antitumor activity of psychotropic drugs and their synergic action with cyclophosphamide . Chem. Pharm. Bull. , 17 , 848 – 850 ( 1969. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES